| Allergic rhinoconjunctivitis in elite athletes: optimal management for quality of life and performance. | |
| | |
MedLine Citation:
|
PMID: 12744714 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
Allergic rhinoconjunctivitis is a common condition with a peak incidence in the age range of the majority of elite athletes. The condition has been shown to have a significant impact on the quality of life of those affected and poses particular challenges when present in the elite athlete. When an athlete is looking for exceptional performance at events such as the Olympic Games, any factor which affects quality of life by interfering with sleep, decreasing the ability to concentrate, or reducing peak physical fitness, may have a significant impact on the ability to perform at one's best. Optimal management begins with correct diagnosis and identification of triggering factors. There are a number of therapeutic options available to the treating physician. When formulating a management plan for the elite athlete, the physician must consider "doping" rules and the possible effect of medication on athletic performance. Medication choices include the newer, non-sedating antihistamines, used either orally or topically, and the prophylactic use of intranasal corticosteroids. When allergic conjunctivitis is the principal problem, the newer, topical antihistamines are highly effective and have a rapid onset of action. Since avoidance strategies are rarely practical for the athlete, consideration should be given to strategies such as immunotherapy, where long-term benefit is possible. |
| | |
Authors:
|
Constance H Katelaris; Fiona M Carrozzi; Therese V Burke |
Related Documents
:
|
11297274 - Egg marketing in national supermarkets: specialty eggs--part 2. 12463954 - Using client-side event logging and path tracing to assess and improve the quality of w... 12459404 - The role of the institutional review board in quality improvement: a survey of quality ... 18799954 - Pa.net international quality certification protocol for blood pressure monitors. 20697674 - Acceptability of medical students by patients from private and public family practices ... 18960394 - Photometric determination of palladium with dimethylsulphonazo iii. |
Publication Detail:
|
Type: Journal Article; Review |
Journal Detail:
|
Title: Sports medicine (Auckland, N.Z.) Volume: 33 ISSN: 0112-1642 ISO Abbreviation: Sports Med Publication Date: 2003 |
Date Detail:
|
Created Date: 2003-05-14 Completed Date: 2003-09-26 Revised Date: 2009-11-03 |
Medline Journal Info:
|
Nlm Unique ID: 8412297 Medline TA: Sports Med Country: New Zealand |
Other Details:
|
Languages: eng Pagination: 401-6 Citation Subset: IM |
Affiliation:
|
Institute of Immunology and Allergy Research, Westmead Hospital, Westmead 2145, Sydney, New South Wales, Australia. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Acute Disease Administration, Intranasal Adrenal Cortex Hormones / administration & dosage Anti-Asthmatic Agents / therapeutic use Chronic Disease Conjunctivitis, Allergic / complications, drug therapy* Histamine H1 Antagonists / therapeutic use Humans Immunotherapy / methods Ipratropium / therapeutic use Nasal Decongestants / therapeutic use Quality of Life* Rhinitis, Allergic, Perennial / complications, drug therapy* Sports Medicine / methods* Task Performance and Analysis* |
| Chemical | |
Reg. No./Substance:
|
0/Adrenal Cortex Hormones; 0/Anti-Asthmatic Agents; 0/Histamine H1 Antagonists; 0/Nasal Decongestants; 60205-81-4/Ipratropium |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Marijuana as doping in sports.
Next Document: The concept of maximal lactate steady state: a bridge between biochemistry, physiology and sport sci...